On Tuesday, Procept BioRobotics Corp (NASDAQ: PRCT) was 3.44% up from the session before settling in for the closing price of $57.59. A 52-week range for PRCT has been $45.56 – $103.81.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 127.16% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 13.70%. With a float of $51.84 million, this company’s outstanding shares have now reached $54.72 million.
In an organization with 756 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 60.5%, operating margin of -43.04%, and the pretax margin is -40.72%.
Procept BioRobotics Corp (PRCT) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Procept BioRobotics Corp stocks. The insider ownership of Procept BioRobotics Corp is 5.43%, while institutional ownership is 92.02%. The most recent insider transaction that took place on Mar 06 ’25, was worth 223,230. In this transaction EVP, CLO, CORP. SEC. of this company sold 3,641 shares at a rate of $61.31, taking the stock ownership to the 61,789 shares. Before that another transaction happened on Mar 06 ’25, when Company’s EVP, Chief Comm. Officer sold 3,588 for $61.31, making the entire transaction worth $219,980. This insider now owns 63,380 shares in total.
Procept BioRobotics Corp (PRCT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.70% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.06% during the next five years compared to -12.56% drop over the previous five years of trading.
Procept BioRobotics Corp (NASDAQ: PRCT) Trading Performance Indicators
You can see what Procept BioRobotics Corp (PRCT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.76, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -0.96 in one year’s time.
Technical Analysis of Procept BioRobotics Corp (PRCT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.0 million. That was better than the volume of 0.97 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 18.58%. Additionally, its Average True Range was 3.97.
During the past 100 days, Procept BioRobotics Corp’s (PRCT) raw stochastic average was set at 7.97%, which indicates a significant decrease from 25.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.20% in the past 14 days, which was higher than the 67.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $71.94, while its 200-day Moving Average is $74.75. However, in the short run, Procept BioRobotics Corp’s stock first resistance to watch stands at $61.06. Second resistance stands at $62.55. The third major resistance level sits at $64.41. If the price goes on to break the first support level at $57.71, it is likely to go to the next support level at $55.85. Assuming the price breaks the second support level, the third support level stands at $54.36.
Procept BioRobotics Corp (NASDAQ: PRCT) Key Stats
There are 54,819K outstanding shares of the company, which has a market capitalization of 3.27 billion. As of now, sales total 224,500 K while income totals -91,410 K. Its latest quarter income was 68,240 K while its last quarter net income were -18,860 K.
